Proinflammatory Dual Receptor T Cells in Chronic Graft-versus-Host Disease

被引:10
|
作者
Balakrishnan, Amritha [1 ]
Gloude, Nicholas [2 ]
Sasik, Roman [3 ]
Ball, Edward D. [4 ]
Morris, Gerald P. [1 ]
机构
[1] Univ Calif San Diego, Dept Pathol, 9500 Gilman Dr,MC 0612, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Ctr Computat Biol & Bioinformat, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
关键词
T cell; Chronic graft-versus-host disease; T cell receptor; TCR; FOLLICULAR HELPER-CELLS; NEGATIVE SELECTION; DE-NOVO; TRANSPLANTATION; EXPRESSION; CD4(+); TCR; REPERTOIRE; ANTIGENS; AUTOIMMUNITY;
D O I
10.1016/j.bbmt.2017.07.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Defective post-transplantation thymopoiesis is associated with chronic graft-versus-host disease (GVHD), a multiorgan pathology affecting up to 80% of patients after allogeneic hematopoietic stem cell transplantation (HSCT). Previous work demonstrated that the subset of T cells expressing 2 T cell receptors (TCRs) is predisposed to alloreactivity, driving selective and disproportionate activity in acute GVHD in both mouse models and HSCT patients. Here we investigate a potential role for this pathogenic T cell subset in chronic GVHD (cGVHD). HSCT patients with cGVHD demonstrated increased numbers of dual TCR cells in circulation. These dual receptor cells had an activated phenotype, indicating an active role in cGVHD. Notably, single-cell RNA sequencing identified the increased dual TCR cells in cGVHD as predominantly expressing Tbet, indicative of a proinflammatory phenotype. These results identify dual TCR cells as specific mediators of pathogenic inflammation underlying cGVHD and highlight Tbet-driven T cell function as a potential pathway for potential therapeutic targeting. (C) 2017 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:1852 / 1860
页数:9
相关论文
共 50 条
  • [41] Updates in chronic graft-versus-host disease
    Hamilton, Betty K.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2021, (01) : 648 - 654
  • [42] Belumosudil for chronic graft-versus-host disease
    Taylor, Breanna
    Cohen, Jaimie
    Tejeda, Jennifer
    Wang, Trent Peng
    DRUGS OF TODAY, 2022, 58 (05) : 203 - 212
  • [43] Chronic polyarthritis and graft-versus-host disease
    NaranjoHernandez, A
    Mataix, R
    RodriguezLozano, C
    BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 (03): : 297 - 298
  • [44] Re: Chronic graft-versus-host disease
    Flowers, MED
    Lee, S
    Vogelsang, G
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (08) : 540 - 540
  • [45] THE MANAGEMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE
    SIADAK, M
    SULLIVAN, KM
    BLOOD REVIEWS, 1994, 8 (03) : 154 - 160
  • [46] Biomarkers in chronic graft-versus-host disease
    Rozmus, Jacob
    Schultz, Kirk R.
    EXPERT REVIEW OF HEMATOLOGY, 2011, 4 (03) : 329 - 342
  • [47] Oral Chronic Graft-Versus-Host Disease
    Dean, David
    Sroussi, Herve
    FRONTIERS IN ORAL HEALTH, 2022, 3
  • [48] THE HOST RESPONSE IN GRAFT-VERSUS-HOST DISEASE .3. THE IN-VITRO INDUCTION OF REGULATORY CELLS IN CHRONIC MURINE GRAFT-VERSUS-HOST DISEASE
    MANN, RA
    SINGH, AB
    JETZT, AE
    SINGH, M
    CELLULAR IMMUNOLOGY, 1995, 164 (01) : 1 - 10
  • [49] Acute graft-versus-host disease overlapping chronic graft-versus-host disease after reinduction chemotherapy
    Delgado-Jimenez, Y
    Goiriz, R
    García-Díez, A
    Fernández-Herrera, J
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB52 - AB52
  • [50] Graft-versus-host disease with acute hair loss: A distinctive manifestation of chronic graft-versus-host disease
    Silveira, Laura
    Fraia e Souza, Maria Natalia
    Teixeira, Solange
    Sternberg, Flavia
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB135 - AB135